Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000348471 | SCV000402698 | uncertain significance | Naxos disease | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000394661 | SCV000402699 | uncertain significance | Arrhythmogenic right ventricular cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000657981 | SCV000779752 | uncertain significance | not provided | 2018-04-04 | criteria provided, single submitter | clinical testing | A variant of uncertain significance has been identified in the JUP gene. The c.2167_2172delGACTAC variant has not been published as pathogenic or been reported as benign to our knowledge. This variant is observed at a global allele frequency of 10/275930 (0.004%) alleles in large population cohorts, including 3/23970 (0.013%) alleles from individuals of African ancestry (Lek et al., 2016). The c.2167_2172delGACTAC variant is predicted to result in the in-frame deletion of two amino acids, denoted p.Asp723_Tyr724del. However, in-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. |
Invitae | RCV000824161 | SCV000965047 | uncertain significance | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2023-12-06 | criteria provided, single submitter | clinical testing | This variant, c.2167_2172del, results in the deletion of 2 amino acid(s) of the JUP protein (p.Asp723_Tyr724del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs782439900, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with JUP-related conditions. ClinVar contains an entry for this variant (Variation ID: 323162). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002429281 | SCV002731346 | likely benign | Cardiovascular phenotype | 2021-07-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV003150161 | SCV003838223 | uncertain significance | Cardiomyopathy | 2022-05-19 | criteria provided, single submitter | clinical testing |